AIM
CASC

Acrospire Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Acrospire Investment Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,074
Closed -$21K – 2789
2017
Q1 		$21K Sell
5,074
-6,210
-55% -$25.7K 0.02% 1617
2016
Q4 		$49K Buy
11,284
+8,678
+333% +$37.7K 0.02% 1414
2016
Q3 		$26K Buy
2,606
+2,419
+1,294% +$24.1K 0.02% 1413
2016
Q2 		$1K Buy
+187
New +$1K ﹤0.01% 1984